Experience
Deep knowledge of your business's most important issues.

Stock Acquisition of Immunostics, Inc.

Foley represented Boditech Med Inc., a Korean in-vitro diagnostic company, in its stock acquisition of Immunostics, Inc., a U.S. in-vitro diagnostics company. The deal closed on March 2, 2016, with a purchase price of $13.625 million. The acquisition positioned Boditech Med to enter the U.S. in-vitro diagnostics market, which is the world’s largest.